Hisanori Muto

Clinical Outcomes With Lenvatinib in Patients Previously Treated With Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma

Hisanori Muto, Teiji Kuzuya, Naoto Kawabe et al. · Anticancer Research · 2023 · 20 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis

Hisanori Muto, Takanori Ito, Taku Tanaka et al. · Scientific Reports · 2021 · 17 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy

Seiichiro Mitani, Shigenori Kadowaki, Hiroya Taniguchi et al. · Case Reports in Oncology · 2016 · 13 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A new criterion including the aspartate aminotransferase‐to‐platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria

Shinya Yokoyama, Yoji Ishizu, Takashi Honda et al. · Hepatology Research · 2023 · 12 citations · Full text

Medicine, Child Health, Pediatrics +17

Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma

Teiji Kuzuya, Naoto Kawabe, Hisanori Muto et al. · Current Oncology · 2024 · 12 citations · Full text

Medicine, Oncology, Pharmacotherapy +17